You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

News

Resolutions at Getinge’s Extraordinary General Meeting

Gothenburg, Sweden December 4, 2017

Resolutions at Getinge’s Extraordinary General Meeting

At the Extraordinary General Meeting of Getinge AB held on December 4, 2017 it was resolved to distribute all shares in Arjo AB (publ) (“Arjo”) to the shareholders of Getinge.

The Meeting resolved in accordance with the Board’s proposal to distribute all shares in the wholly-owned subsidiary Arjo, whereby one (1) share of series A in Getinge AB entitles to one (1) share of series A in Arjo and one (1) share of series B in Getinge AB entitles to one (1) share of series B in Arjo.

The record date for distribution is Friday, December 8, 2017. With the proposed record date, the shares in Arjo are expected to be registered in the securities account of the recipient on or about Tuesday, December 12, 2017. The final day of trading in Getinge’s shares including the right to distribution will be Wednesday, December 6, 2017. The shares of series B in Arjo are intended to be traded on Nasdaq Stockholm and the first day of trading in the shares is expected to be Tuesday, December 12, 2017.


For further information, please contact:

Jeanette Hedén Carlsson,
Executive Vice President Communications & Brand Management
Telephone: +46 (0)10 335 10 03
Email:
jeanette.hedencarlsson@getinge.com 

Lars Mattsson,
Head of Investor Relations
Telephone: +46 (0)10 335 00 43
E-mail:
lars.mattsson@getinge.com 

About Getinge
Getinge is a global provider of innovative solutions for operating rooms, intensive care units, sterilization departments and for life science companies and institutions. Based on our firsthand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the everyday life for people - today and tomorrow.

Teilen: